首页> 外国专利> HYDRAZINE COMPOUND AS BLOOD COAGULATION FACTOR Xa INHIBITOR

HYDRAZINE COMPOUND AS BLOOD COAGULATION FACTOR Xa INHIBITOR

机译:肼化合物作为凝血因子Xa抑制剂

摘要

Provided is a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein X is selected from a 3-9 membered carbon ring or its phenyl ring, and a 4-10 membered heterocyclic ring or its benzo ring; Y and Z are independently selected from 4-9 membered saturated heterocyclic rings respectively; R I-3 are independently selected from H, F, Cl, Br, I, CN, OH, SH,NH 2 , CHO, COOH respectively, or selected from C 1-10 alkyls or heteroalkyls optionally substituted by R 01 , C 3-10 alkyls ring hydrocarbon groups or heterocyclic hydrocarbon groups, C 1-10 alkyls or heteroalkyls substituted by C 3-10 ring hydrocarbon groups or heterocyclic hydrocarbon group. The compound can be used as an anticoagulant for treating and preventing thrombotic disorders, and can meet the real needs of selectivity and a potent inhibitor for coagulation Xa.
机译:提供式(I)的化合物或其药学上可接受的盐,其中X选自3-9元碳环或其苯环和4-10元杂环或其苯并环; Y和Z分别独立地选自4-9元饱和杂环; R I-3分别独立地选自H,F,Cl,Br,I,CN,OH,SH,NH 2,CHO,COOH,或选自C 1-10烷基或任选地被R 01,C 3取代的杂烷基-10个烷基的环烃基或杂环烃基,被C 3-10的环烃基或杂环烃基取代的C 1-10烷基或杂烷基。该化合物可以用作治疗和预防血栓形成疾病的抗凝剂,并且可以满足选择性的真正需求和有效的凝血抑制剂Xa。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号